Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis?

G Querci della Rovere ¹, John R Benson

⁰Department of Surgery, Royal Marsden Hospital, Sutton, UK.

The Lancet. Oncology +

|

March 22, 2002

View abstract on PubMed

Summary

Ipsilateral local recurrence in breast cancer is a marker of distant relapse when micrometastases are present. Tailoring treatment intensity based on micrometastatic status can optimize patient outcomes and avoid overtreatment.

Area Of Science

Oncology
Breast Cancer Research
Surgical Oncology

Background

The significance of ipsilateral local recurrence in breast conservation is influenced by the patient's micrometastatic environment at diagnosis.
Local recurrence indicates distant disease if micrometastases are absent, but signifies distant relapse when micrometastases are present.

Purpose Of The Study

To investigate a selective treatment approach for postmenopausal women with small tumors, differentiating based on micrometastatic status.
To compare conventional treatment versus a minimum-therapy-at-presentation-plus-maximum-therapy-at-local-relapse strategy.

Main Methods

The study proposes a clinical trial comparing two treatment arms.
One arm receives conventional treatment; the other receives minimum therapy initially, escalating to maximum therapy upon local recurrence.

Main Results

The presence of local recurrence is an indicator of poor prognosis.
A selective treatment approach can prevent overtreatment in certain patient groups.

Conclusions

Treatment intensity for local recurrence should be individualized based on the initial micrometastatic environment.
This selective approach may improve outcomes and reduce unnecessary interventions for breast cancer patients.

Related Concept Videos